SC
RVMD icon

Sawyer & Company’s Revolution Medicines RVMD Stock Holding History

Sawyer & Company’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$936 Buy
+5
New +$730 ﹤0.01% 198
2025
Q3 		– Sell
-5
Closed -$936 – 208
2025
Q2 		$936 Buy
+5
New +$192 ﹤0.01% 198

Other funds holding RVMD

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Sawyer & Company's RVMD Position: Q2 2026 in Review

Sawyer & Company opened a new position in Revolution Medicines (RVMD) in Q2 2026: 5 shares worth $936. The stake represents ﹤0.01% of the portfolio and ranks #198 among its holdings. This is a return to the name: Sawyer & Company previously reported a position in RVMD as recently as Q2 2025.

Sawyer & Company first reported a position in RVMD in Q2 2025 and has held it in 2 quarters since. 199 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Sawyer & Company held 5 shares of Revolution Medicines worth $936 as of Q2 2026.
  • Revolution Medicines was a new Sawyer & Company position in Q2 2026.
  • Revolution Medicines made up ﹤0.01% of Sawyer & Company's portfolio in Q2 2026, its #198 holding.
  • Sawyer & Company first reported a position in Revolution Medicines in Q2 2025 and has held it in 2 quarters since.
  • 199 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Sawyer & Company's 13F filing for Q2 2026, filed 23 Jul 2026.